China to turn around on the prevention of hepatitis E
The Chinese market came the worlds first vaccine against hepatitis E, called "Hecolin", reported Xinhua. It is known that the manufacturer of the vaccine tested it for two years, involving 113,000 volunteers from Jiangsu Province.
Vaccine developer by the University and the company Xiamen Xiamen Innovax Biotech Co. Ltd. "Welcome" in the production of the vaccine was received in December 2011. Currently, the company Xiamen Innovax Biotech Co. Ltd. cooperating with the government. The purpose – to facilitate access to the vaccine people at risk.
Also negotiating with international organizations with a view to introducing the vaccine in other countries. As for hepatitis E is the most common type of hepatitis in China, affecting adults. High incidence found in South and South-East Asia, Africa and Central America.
This viral disease is fecal-oral contamination. It is prone to epidemic spread. The source of infection appears sick man, but there is evidence that the virus can replicate in the body of the pigs. In 70% of cases of hepatitis is characterized by pain.
It is particularly dangerous for pregnant women and people with liver disease, as occurs in severe form. Pregnant develops so-called fulminant hepatitis, threatening acute liver failure. Fatality rate can reach 30%.